Lotus Eye Hospital and Institute Balance Sheet Health
Financial Health criteria checks 6/6
Lotus Eye Hospital and Institute has a total shareholder equity of ₹601.1M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹700.7M and ₹99.7M respectively. Lotus Eye Hospital and Institute's EBIT is ₹12.0M making its interest coverage ratio -4.1. It has cash and short-term investments of ₹45.4M.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | -4.1x |
| Cash | ₹45.45m |
| Equity | ₹601.06m |
| Total liabilities | ₹99.69m |
| Total assets | ₹700.75m |
Recent financial health updates
No updates
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06Financial Position Analysis
Short Term Liabilities: LOTUSEYE's short term assets (₹117.8M) exceed its short term liabilities (₹77.5M).
Long Term Liabilities: LOTUSEYE's short term assets (₹117.8M) exceed its long term liabilities (₹22.2M).
Debt to Equity History and Analysis
Debt Level: LOTUSEYE is debt free.
Reducing Debt: LOTUSEYE had no debt 5 years ago.
Debt Coverage: LOTUSEYE has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: LOTUSEYE has no debt, therefore coverage of interest payments is not a concern.